Can thalidomide improve outcome in patients with multiple myeloma?

被引：0
|
作者：
Paul G Richardson
Constantine S Mitsiades
Nikhil C Munshi
Kenneth C Anderson
机构：
[1] the Clinical Director of the Jerome Lipper Multiple Myeloma Center (JLMMC) at the Dana-Farber Cancer Institute (DFCI),Instructor in Medicine at Harvard Medical School (HMS)
[2] the Department of Medical Oncology of DFCI and the Department of Medicine at Brigham and Women's Hospital,undefined
[3] the Associate Director of the JLMMC of DFCI,undefined
[4] Associate Professor of Medicine at HMS,undefined
[5] the Director of the JLMMC,undefined
[6] Chief of Division of Hematologic Neoplasia at DFCI and the Kraft Family Professor of Medicine at HMS,undefined
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：590 / 591
页数：1
相关论文
共 50 条
  • [21] Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism
    Talamo, Giampaolo P.
    Ibrahim, Sulfi
    Claxton, David
    Tricot, Guido J.
    Fink, Louis M.
    Zangari, Maurizio
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (05) : 337 - 339
  • [22] Thalidomide shows promising results in patients with multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 1999, 13 (05): : 744 - 744
  • [23] THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE
    Palmaro, A.
    Despas, F.
    Lapeyre-Mestre, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E65 - E65
  • [24] Thalidomide treatment of resistant or relapsed multiple myeloma patients
    Hus, M
    Dmoszynska, A
    Soroka-Wojtaszko, M
    Jawniak, D
    Legiec, W
    Ciepnuch, H
    Hellmann, A
    Wolska-Smolen, T
    Skotnicki, A
    Manko, J
    HAEMATOLOGICA, 2001, 86 (04) : 404 - 408
  • [25] Dermatologic side effects of thalidomide in patients with multiple myeloma
    Hall, VC
    El-Azhary, RA
    Bouwhuis, S
    Rajkumar, SV
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (04) : 548 - 552
  • [26] THE MAINTENANCE THERAPY WITH THALIDOMIDE IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Bila, J.
    Lekovic, D.
    Smiljanic, M.
    Sretenovic, A.
    Andjelic, B.
    Vidovic, A.
    Todorovic, M.
    Elezovic, I.
    Tomin, D.
    Gotic, M.
    Mihaljevic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 583 - 583
  • [27] Impact of thalidomide on survival of patients with multiple myeloma.
    Fawaz, A
    Magro, L
    Leleu, X
    Depil, S
    Guillerm, G
    Corm, S
    Bauters, F
    Facon, T
    Yakoub-Agha, I
    BLOOD, 2002, 100 (11) : 384B - 384B
  • [28] Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
    Mian, Michael
    Tinelli, Martina
    De March, Elena
    Turri, Gloria
    Meneghini, Vittorio
    Pescosta, Norbert
    Berno, Tamara
    Marabese, Alessandra
    Mondello, Patrizia
    Patriarca, Francesca
    Pizzolo, Giovanni
    Semenzato, Gianpietro
    Cortelazzo, Sergio
    Zambello, Renato
    ANTICANCER RESEARCH, 2016, 36 (03) : 1059 - 1065
  • [29] Thalidomide maintenance in multiple myeloma
    Jacob P. Laubach
    Paul G. Richardson
    Kenneth C. Anderson
    Nature Reviews Clinical Oncology, 2009, 6 : 565 - 566
  • [30] Thalidomide in multiple myeloma - Reply
    Barlogie, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13): : 975 - 976
12345